Author: Jessica.F

Miranda, Alexandre S.; Marcos, Paula M.; Ascenso, Jose R.; Robalo, M. Paula; Bonifacio, Vasco D. B.; Berberan-Santos, Mario N.; Hickey, Neal; Geremia, Silvano published an article in 2021, the title of the article was Conventional vs. microwave- or mechanically-assisted synthesis of dihomooxacalix[4]arene phthalimides: NMR, X-ray and photophysical analysis.Product Details of 574-98-1 And the article contains the following content:

Direct O-alkylation of p-tert-Bu dihomooxacalix[4]arene with N-(bromopropyl)- or N-(bromoethyl)phthalimides and K2CO3 in acetonitrile were conducted under conventional heating (reflux) and using microwave irradiation and ball milling methodologies. The reactions afforded mono- and mainly distal di-substituted derivatives in the cone conformation, in a total of eight compounds I [Y1=Y2=Y3=Y4 = H, phthalimidoethyl, phthalimidopropyl]. The compounds I were isolated by column chromatog., and their conformations and the substitution patterns were established by NMR spectroscopy (1H, 13C, COSY and NOESY experiments). The X-ray structures of four dihomooxacalix[4]arene phthalimide derivatives I[Y1=Y2=Y3 = H, Y4 = phthalimidopropyl or phthalimidoethyl; Y1=Y3 = phthalimidopropyl, Y2=Y4 = H; Y1=Y2 = H, Y3=Y4 = phthalimidopropyl] were reported, as well as their photophys. properties. The microwave (MW)-assisted alkylations drastically reduced the reaction times (from days to less than 45 min) and produced higher yields of both 1,3-di-substituted phthalimides I [Y1=Y3 = phthalimidoethyl; Y2=Y4 = H, Y1=Y3 = phthalimidopropyl; Y2=Y4 = H] with higher selectivity. Ball milling did not revealed to be a good method for this kind of reaction. The experimental process involved the reaction of 2-(2-Bromoethyl)isoindoline-1,3-dione(cas: 574-98-1).Product Details of 574-98-1

The Article related to dihomooxacalixarene bromolalkyl phthalimide alkylation microwave, phthalimidoalkoxy dihomooxacalixarene preparation crystal structure, nmr spectroscopy, x-ray diffraction, ball milling, conventional synthesis, dihomooxacalix[4]arenes, electronic absorption and fluorescence studies, microwave irradiation, phthalimide derivatives and other aspects.Product Details of 574-98-1

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

On May 6, 1999, Thompson, Mervyn; Harling, John David; Edwards, Peter David published a patent.Product Details of 90326-61-7 The title of the patent was Preparation of substituted isoquinolines as anticonvulsants. And the patent contained the following:

The title compounds [I; n, p = 1-4 and n + p = 2-5; R1 = H, cycloalkylO, etc.; R2 = H, halo, CN, etc.; R3 = H, halo, NO2, etc.; R2R3 = (un)substituted (un)saturated carbocyclic ring; R4 = H, alkyl, alkenyl, etc.], useful as anticonvulsants, were prepared Thus, conversion of 2-ethoxy-4-isopropyl-5-cyanobenzoic acid into the acid chloride followed by coupling with 5-amino-2-methyl-1,2,3,4-tetrahydroisoquinoline afforded 60% II.HCl which showed a 336% increase in seizure threshold for rat MEST. Compounds I are useful in the prophylaxis and treatment of anxiety, mania, depression, panic disorders and/or aggression, disorders associated with a subarachnoid hemorrhage or neural shock, the effects associated with withdrawal from substances of abuse such as cocaine, nicotine, alc. and benzodiazepines, disorders treatable and/or preventable with anti-convulsive agents, such as epilepsy including post-traumatic epilepsy, Parkinson’s disease, psychosis, migraine, cerebral ischemia, Alzheimer’s disease and other degenerative diseases such as Huntington’s chorea, schizophrenia, obsessive compulsive disorders (OCD), neurol. deficits associated with AIDS, sleep disorders (including circadian rhythm disorders, insomnia and narcolepsy), tics (e.g. Giles de la Tourette’s syndrome), traumatic brain injury, tinnitus, neuralgia, especially trigeminal neuralgia, neuropathic pain, dental pain, cancer pain, inappropriate neuronal activity resulting in neurodysthesias in diseases such as diabetes, multiple sclerosis (MS) and motor neuron disease, ataxias, muscular rigidity (spasticity), temporomandibular joint dysfunction and amyotrophic lateral sclerosis (ALS). The experimental process involved the reaction of 5-Bromo-2-methoxy-4-methylbenzoic acid(cas: 90326-61-7).Product Details of 90326-61-7

The Article related to isoquinoline preparation anticonvulsant, anxiolytic isoquinoline preparation, antidepressant isoquinoline preparation, substance abuse isoquinoline preparation, parkinson disease isoquinoline preparation, alzheimer disease isoquinoline preparation, antipsychotic isoquinoline preparation, huntington chorea isoquinoline preparation and other aspects.Product Details of 90326-61-7

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Oliver, Martin; Le Corre, Laurent; Poinsot, Melanie; Corio, Alessandra; Madegard, Lea; Bosco, Michael; Amoroso, Ana; Joris, Bernard; Auger, Rodolphe; Touze, Thierry; Bouhss, Ahmed; Calvet-Vitale, Sandrine; Gravier-Pelletier, Christine published an article in 2021, the title of the article was Synthesis, biological evaluation and molecular modeling of urea-containing MraY inhibitors.Computed Properties of 574-98-1 And the article contains the following content:

The straightforward synthesis of aminoribosyl uridines substituted by a 5′-methylene-urea is described. 90Their convergent synthesis involves the urea formation from various activated amides and an azidoribosyl uridine substituted at the 5′ position by an aminomethyl group. This common intermediate resulted from the diastereoselective glycosylation of a phthalimido uridine derivative with a ribosyl fluoride as a ribosyl donor. The inhibition of the MraY transferase activity by the synthesized 11 urea-containing inhibitors was evaluated and 10 compounds revealed MraY inhibition with IC50 ranging from 1.9μM to 16.7μM. Their antibacterial activity was also evaluated on a panel of Gram-pos. and Gram-neg. bacteria. Four compounds exhibited a good activity against Gram-pos. bacterial pathogens with MIC ranging from 8 to 32μg mL-1, including methicillin resistant Staphylococcus aureus (MRSA) and Enterococcus faecium. Interestingly, one compound also revealed antibacterial activity against Pseudomonas aeruginosa with MIC equal to 64μg mL-1. Docking experiments predicted two modes of positioning of the active compounds urea chain in different hydrophobic areas (HS2 and HS4) within the MraY active site from Aquifex aeolicus. However, mol. dynamics simulations showed that the urea chain adopts a binding mode similar to that observed in 5CKR structural model and targets the hydrophobic area HS2. The experimental process involved the reaction of 2-(2-Bromoethyl)isoindoline-1,3-dione(cas: 574-98-1).Computed Properties of 574-98-1

The Article related to stereoselective glycosylation nucleoside mol modeling enzyme active site, methicillin drug resistant staphylococcus aureus enterococcus faecium hydrogen bond, peptide mol modeling urea mray antibacterial enzyme active site, mol modeling inhibitor mray inhibitor synthesis antibacterial transferase phosphoacetylmuramoylpeptidetransferase and other aspects.Computed Properties of 574-98-1

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

On April 16, 2021, Xu, Changming; Qi, Yinsheng; Yang, Xinshuang; Li, Xiangfan; Li, Zhenpeng; Bai, Lei published an article.Safety of 4-(Bromomethyl)-1,1′-biphenyl The title of the article was Development of C2-Symmetric Chiral Spirocyclic Phase-Transfer Catalysts: Synthesis and Application to Asymmetric Alkylation of Glycinate Schiff Base. And the article contained the following:

A class of C2-sym. chiral spirocyclic phase-transfer catalysts based on the tetramethyl-1,1′-spirobiindane scaffold such as I·Br- was synthesized from com. available bisphenol A in 12 steps in 22-25% total yields; the scaffold features a more rigid and stable backbone and smaller dihedral angles and can be easily modified. These catalysts show high catalytic performance in the asym. alkylation of tert-Bu glycinate Schiff base Ph2C:NCH2CO2t-Bu at only 2 mol % catalyst loading, giving nonracemic protected α-amino acid esters such as (R)-Ph2C:NCH(CH2Ph)CO2t-Bu in up to 92% yield and 98% ee. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Safety of 4-(Bromomethyl)-1,1′-biphenyl

The Article related to spirobiindanoazocinium nonracemic preparation catalyst enantioselective phase transfer alkylation, diphenylmethyleneamino ester enantioselective preparation, nonracemic spirobiindanoazocinium bromide enantioselective phase transfer alkylation catalyst, alkyl bromide enantioselective alkylation diphenylmethyleneamino ester spirobiindanoazocinium catalyst and other aspects.Safety of 4-(Bromomethyl)-1,1′-biphenyl

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

On September 5, 2022, Zhang, Yan-Dong; Li, Xiao-Yu; Mo, Qian-Kun; Shi, Wen-Bin; Zhao, Jia-Bao; Zhu, Shou-Fei published an article.HPLC of Formula: 2567-29-5 The title of the article was Highly Regioselective Cobalt-Catalyzed Hydroboration of Internal Alkynes. And the article contained the following:

Herein, we report the development of new Co complexes that have cyclopropane-based diphosphine ligands and can catalyze highly chemo-, regio-, and stereoselective hydroboration reactions of unsym. internal alkynes. These reactions exhibited unusual regioselectivity: specifically, reactions of aryl alkyl internal alkynes showed excellent cis-β-addition selectivity, and reactions of dialkyl internal alkynes gave excellent cis-α-addition selectivity. Highly regioselective hydroboration of unsym. dialkyl internal alkynes cannot be achieved by other known methods. The reactions described herein are highly synthetically useful, particularly for the stereoselective synthesis of trisubstituted alkenylborates and alkenes. Mechanistic studies indicate that a CoI-H species is a plausible active catalyst and the rigid structure of the cyclopropane skeleton of the ligands and the crowded reaction pocket were responsible for the unprecedented regioselectivity. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).HPLC of Formula: 2567-29-5

The Article related to regioselective stereoselective cobalt catalyst hydroboration internal alkyne dft mechanism, cobalt cyclopropanediphosphine complex preparation catalyst regioselective hydroboration internal alkyne, crystal structure mol cobalt cyclopropane diphosphine complex preparation, alkenylborates, cobalt catalysis, diphosphine ligands, hydroboration, internal alkynes and other aspects.HPLC of Formula: 2567-29-5

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

On June 23, 2011, Hardy, Larry Wendell; Heffernan, Michele L. R.; Wu, Frank Xinhe; Spear, Kerry L.; Saraswat, Lakshmi D. published a patent.Reference of 2-Amino-6-bromonicotinic acid The title of the patent was Preparation of substituted quinazolinones and their analogs for treating disorders mediated by metabotropic glutamate receptor 5. And the patent contained the following:

The title compounds I [R1 = H, alkyl, heteroalkyl, etc.; R2 = H, alkyl, cycloalkyl, etc.; R3 = H, alkyl, heteroalkyl, etc.; G = CHR2 or NR2 when b and c are both single bonds, or G = CR2 or N when one of b and c is a double bond; Q = NH or CH2 when d and e are single bonds, or N or CH one of d or e is a double bond; X = CH or N when f is a single bond, or C when f is a double bond; Z = CH2, C(O), C(S) or a bond when b is a single bond, or CH or N when b is a double bond; Y1-Y3 = CH, C(halo), C(alkyl), N (provided that no more than one of Y2 and Y3 = N); L1 = CC, HC=CH, CH2CH2, etc.] which modulate the activity of metabotropic glutamate receptor 5 (mGluR5) in the central nervous system or the periphery, and therefore are useful for the treatment, prevention, and/or management of various disorders, such as neurol. disorders, neurodegenerative disorders, neuropsychiatric disorders, disorders of cognition, learning or memory, gastrointestinal disorders, lower urinary tract disorder, and cancer, were prepared Thus, Pd-catalyzed coupling of 7-bromoquinazolin-4(3H)-one with 1-ethynyl-4-fluorobenzene afforded II. Exemplified compounds I were tested in in vitro cell-based assay for modulation of the activation of mGluR5 by glutamate (data given for representative compounds I). Pharmaceutical formulations containing the compounds I and their methods of use are also provided herein. The experimental process involved the reaction of 2-Amino-6-bromonicotinic acid(cas: 1196157-51-3).Reference of 2-Amino-6-bromonicotinic acid

The Article related to quinazolinone pyridoquinazolinone pyridopyrimidinone diazepinoquinazolinone preparation metabotropic glutamate receptor mglur5, neurol neurodegenerative neuropsychiatric learning memory disorder treatment quinazolinone preparation, cognition enhancer gastrointestinal antitumor quinazolinone pyridoquinazolinone pyridopyrimidinone diazepinoquinazolinone preparation and other aspects.Reference of 2-Amino-6-bromonicotinic acid

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

On September 30, 2021, Al-Hamashi, Ayad A.; Chen, Dongxing; Deng, Youchao; Dong, Guangping; Huang, Rong published an article.Application of 574-98-1 The title of the article was Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5. And the article contained the following:

Protein arginine methyltransferases (PRMTs) have been implicated in the progression of many diseases. Understanding substrate recognition and specificity of individual PRMT would facilitate the discovery of selective inhibitors towards future drug discovery. Herein, we reported the design and synthesis of bisubstrate analogs for PRMTs that incorporate a S-adenosylmethionine (SAM) analog moiety and a tripeptide through an alkyl substituted guanidino group. Compound AH237 is a potent and selective inhibitor for PRMT4 and PRMT5 with a half-maximal inhibition concentration (IC50) of 2.8 and 0.42 nmol/L, resp. Computational studies provided a plausible explanation for the high potency and selectivity of AH237 for PRMT4/5 over other 40 methyltransferases. This proof-of-principle study outlines an applicable strategy to develop potent and selective bisubstrate inhibitors for PRMTs, providing valuable probes for future structural studies. The experimental process involved the reaction of 2-(2-Bromoethyl)isoindoline-1,3-dione(cas: 574-98-1).Application of 574-98-1

The Article related to amino acids role: bsu (biological study, unclassified), biol (biological study), computational biology, drug design, homo sapiens, human, methylation, molecular docking, molecular modeling, tripeptides role: bsu (biological study, unclassified), biol (biological study) (rgk), tripeptides role: bsu (biological study, unclassified), biol (biological study) (rgr) and other aspects.Application of 574-98-1

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary